866-997-4948(US-Canada Toll Free)

Metastatic Colorectal Cancer Global Clinical Trials Review, H2, 2017

Published By :

GlobalData

Published Date : Dec 2017

Category :

Pharmaceutical

No. of Pages : 1293 Pages

Metastatic Colorectal Cancer Global Clinical Trials Review, H2, 2017

Summary

GlobalData's clinical trial report, Metastatic Colorectal Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Metastatic Colorectal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Metastatic Colorectal Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Metastatic Colorectal Cancer Therapeutics Clinical Trials 29
Prominent Drugs 30
Latest Clinical Trials News on Metastatic Colorectal Cancer 31
Dec 17, 2017: JHL Submits Clinical Trial Application for Proposed Bevacizumab Biosimilar 31
Dec 01, 2017: First patient included in Phase I study aiming at supporting expansion of global Phase III program for PledOx to include Asian patients 31
Nov 28, 2017: MOLOGEN to Present Poster on Lefitolimod at ESMO IO 2017 31
Nov 18, 2017: Study Shows New Second Line Therapy for Metastatic Colorectal Cancer is Effective and Safe 31
Oct 09, 2017: First patient treated with microscopic beads pre-loaded with a targeted cancer drug and visible on CT scans 32
Oct 04, 2017: eFFECTOR Therapeutics Initiates Dosing in Phase 2 Combination Trial of eFT508 and Avelumab in Microsatellite Stable Colorectal Cancer 33
Oct 03, 2017: NOXXON Publishes Preclinical Proof-of-Concept Data for Lead Compound NOX-A12 in Combination with Checkpoint Inhibitors 34
Sep 27, 2017: Aduro Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Personalized Immunotherapy pLADD Based on Proprietary Neoantigen Technology 34
Clinical Trial Profile Snapshots 35
Appendix 1290
Abbreviations 1290
Definitions 1290
Research Methodology 1291
Secondary Research 1291
About GlobalData 1292
Contact Us 1292
Disclaimer 1292
Source 1293

List of Tables
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Region, 2017* 8
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
Metastatic Colorectal Cancer Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 14
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 15
Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 16
Metastatic Colorectal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Metastatic Colorectal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 19
Metastatic Colorectal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
Metastatic Colorectal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Phase, 2017* 22
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
Metastatic Colorectal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30

List of Figures
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Region (%), 2017* 8
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
Metastatic Colorectal Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 14
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 15
Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 16
Metastatic Colorectal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Metastatic Colorectal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 19
Metastatic Colorectal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
Metastatic Colorectal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 23
Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
Metastatic Colorectal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30
GlobalData Methodology 1291

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *